scholarly journals Evaluation of the effectiveness of drug treatment in patients with arterial hypertension and insomnia

2021 ◽  
Vol 2 (4) ◽  
pp. 49-59
Author(s):  
I. N. Vasilieva ◽  
A. I. Chesnikova ◽  
O. S. Klimenkova ◽  
A. M. Bikmetova
Keyword(s):  
Blood Pressure ◽  
Arterial Hypertension ◽  
Ace Inhibitor ◽  
Combined Therapy ◽  
Blood Pressure Level ◽  
Biological Rhythms ◽  
Initial Therapy ◽  
Clinical State ◽  
Comorbid Condition ◽  
Synthetic Analogue

Objective: chronic sleep disturbance is a comorbid condition with arterial hypertension, often combined with affective disorders, anxiety, depression. Forced sleep deprivation in patients with hypertension indicates a high activity of the renin‑angiotensin‑aldosterone system (RAAS) and desynchronosis of biological rhythms caused by a probable deficit in melatonin secretion during the night. Timely elimination of any pathological process associated with insomnia and arterial hypertension (AH) in the early stages of its development is a prerequisite for the effectiveness of therapy. Therefore, initial therapy should help neutralize the adverse effects of RAAS and improve the 24‑hour blood pressure (BP) profile. The aim of this study was to determine the therapeutic effect of monotherapy with an angiotensin converting enzyme (ACE) inhibitor, As well as in combination with a synthetic analogue of melatonin, on the course of hypertension and parameters of systemic hemodynamics in patients with first degree hypertension with insomnia at the onset of the disease. Combined therapy with an ACE inhibitor and a synthetic analogue of MT in patients with hypertension and insomnia was accompanied by an improvement in the clinical state, achievement of the target blood pressure level in most patients, positive dynamics of central blood pressure parameters and indicators reflecting the rigidity of peripheral arteries.

scholarly journals Effectiveness and safety of the ACE inhibitor and diuretic combination in postmenopausal women with arterial hypertension

2011 ◽  
Vol 10 (3) ◽  
pp. 35-39
Author(s):  
G. G. Semenkova ◽  
E. E. Matvienko
Keyword(s):  
Quality Of Life ◽  
Blood Pressure ◽  
Combination Therapy ◽  
Arterial Hypertension ◽  
Postmenopausal Women ◽  
Ace Inhibitor ◽  
Comparison Group ◽  
Combined Therapy ◽  
Modified Release

Aim. To assess effectiveness, tolerability, and safety of combined antihypertensive therapy (AHT) with an ACE inhibitor (perindopril) and thiazide-like diuretic (indapamide) in postmenopausal women with arterial hypertension (AH). Material and methods. This open, one-centre study included 43 postmenopausal women with AH. For 3 months, the patients in the main group (MG; n=22) received indapamide MR (modified release) (1,5 mg/d) and perindopril. The comparison group (CG; n=21) was administered non-MR indapamide (2,5 mg/d) and perindopril. The dynamics of office blood pressure (BP) levels, 24-hour BP monitoring parameters, laboratory parameters, quality of life (QoL), as well as therapy safety and tolerability, was assessed. Results. In both groups, the treatment was clinically effective, safe, and QoL-improving. Target BP levels were achieved in the majority of the patients: 85,3 % and 72,4 % in the MG and CG, respectively. The combination therapy including indapamide MR provided greater improvement of circadian BP rhythm, larger reduction in both morning BP surge and increased BP variability, as well as target BP achievement in higher proportion of the patients. Conclusion. In postmenopausal women with AH, combined therapy with perindopril and indapamide MR provided more benefits, compared to the treatment with perindopril and non-MR indapamide.

scholarly journals Modern approaches to combined therapy of arterial hypertension

2013 ◽  
Vol 10 (4) ◽  
pp. 44-49
Author(s):  
D A Napalkov ◽  
A V Zhilenko
Keyword(s):  
Blood Pressure ◽  
Calcium Antagonist ◽  
Arterial Hypertension ◽  
High Blood Pressure ◽  
Ace Inhibitor ◽  
Combined Therapy ◽  
European Guidelines

The article discusses some of the changes in the 2013 European Guidelines in comparison with the previous revision with an emphasis on practical activities of cardiologists and therapists as well as the combined therapy of high blood pressure. Also, special attention is paid to one of the preferred combinations of antihypertensives – a combination of ACE inhibitor and calcium antagonist and, in particular perindopril and amlodipine.

scholarly journals Effects on cognitive function, psychoemotional state, efficiacy and safety of antihypertensive therapy by metoprolol retard in females with the mild to moderate hypertension

2006 ◽  
Vol 12 (4) ◽  
pp. 358-361
Author(s):  
T. S. Poljatykina ◽  
I. E. Mishina ◽  
G. I. Bulychev ◽  
V. L. Geller ◽  
G. I. Sevastjanova ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Essential Hypertension ◽  
Cognitive Function ◽  
Arterial Hypertension ◽  
Antihypertensive Therapy ◽  
Moderate Hypertension ◽  
Combined Therapy ◽  
Psychoemotional State ◽  
Long Acting

The paper presents the results of research in which 50 women with essential hypertension illness (arterial hypertension I-II degree) have taken part. 20 patients received long-acting metoprolol therapy (Egilok - retard, EGIS AO) in the dose of 25-100 mg, if necessary in a combination with hydrochlorothiazide 25 mg. In group of comparison (30 subjects) treatment with enalapril (5-10 mg/сут) or by a combination of enalapril and hydrochlorothiazide was administarted. It is shown, that monotherapy by metoprolol-retard allowed to reach a «target» levels of blood pressure in 89,5 % of women, in 10,5 % cases the combined therapy was required. At 12-week of treatment significant improvement of parameters of concentration of attention and anxiety decrease was observed.

scholarly journals Tactics of antihypertensive therapy during COVID-19 pandemic

2021 ◽  
Vol 93 (9) ◽  
pp. 1125-1131
Author(s):  
Valery I. Podzolkov ◽  
Anna Е. Bragina ◽  
Yulia N. Rodionova ◽  
Galina I. Bragina ◽  
Ekaterina E. Bykova
Keyword(s):  
Blood Pressure ◽  
Cardiovascular Diseases ◽  
Arterial Hypertension ◽  
Ace Inhibitor ◽  
Fixed Combination ◽  
Significant Risk ◽  
Effective Control ◽  
Combination Drug ◽  
Renin Angiotensin Aldosterone System ◽  
Renin Angiotensin

Results of foreign and Russian studies indicate a higher mortality rate of patients with concomitant cardiovascular diseases (CVD) due to the new coronavirus infection COVID-19. It has been proven that arterial hypertension, as one of the significant risk factors for the development of concomitant cardiovascular diseases, is associated with a more severe prognosis of COVID-19. This article presents the results of modern studies and large meta-analyzes of necessity and safety of the use of blockers of the renin-angiotensin-aldosterone system in patients with arterial hypertension and COVID-19. The data of studies show that an angiotensin-converting enzyme inhibitor (ACE inhibitor) and a thiazide-like diuretic is a pathogenetically rational combination. It realizes various ways of lowering blood pressure by reducing the activity of the renin-angiotensin-aldosterone system, which is achieved by using an ACE inhibitor, and natriuresis due to diuretics. As an example, a highly effective fixed combination of drugs is considered, characterized by good tolerance, which consists of an ACE inhibitor lisinopril and a thiazide-like diuretic indapamide of prolonged action. The authors expressed the opinion that the appointment of the fixed combination drug Diroton Plus (Gedeon Richter) will contribute to effective control of blood pressure and organoprotection in conditions of increased thrombogenic and prooxidative potential, characteristic of COVID-19 both in the acute stage and within the post-COVID Syndrome.

Desynchronizing effects of comorbid pathology: psoriasis and arterial hypertension

2014 ◽  
Vol 20 (29) ◽  
pp. 21-24
Author(s):  
Рагозин ◽  
Roman Ragozin
Keyword(s):  
Blood Pressure ◽  
Comparative Analysis ◽  
Arterial Hypertension ◽  
Diurnal Variation ◽  
Diastolic Blood Pressure ◽  
Biological Rhythms ◽  
Northern Region ◽  
Rhythmic Pattern ◽  
Ultradian Rhythms

The paper describes the results of the analysis of biological rhythms of blood pressure in patients with living in the northern region. The comparative analysis of chronograms of blood pressure shows that rhythmic pattern changes with the appearing of short ultradian rhythms, the decrease of phases dispersion of the studied arameters, reducing synchronization between systolic and diastolic blood pressure and diurnal variation of synchronization re observed in patients with psoriasis.

Sign in / Sign up

Export Citation Format

Share Document